Clinical trial

β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation

NCT01944033

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-07-01

PhasePHASE3

Study timeline

Study start (unknown)2013-07-01Date precision: month

Registry last updated2018-01-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acute Exacerbation of Chronic Obstructive Airways Diseaseunresolved

Interventions

Bricanyl/IproventDRUG

BricanylDRUG

Sponsors & collaborators

University of Monastirlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01944033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.